Michel Dreano

Part of RELIEF THERAPEUTICS Holding SA, Pierrel Research International AG provides drug development and clinical research services. The company is based in Essen, Germany. The CEO of the German company is Luigi Visani. Pierrel Research International was acquired by THERAMetrics holding AG from Pierrel SpA on January 25, 2013.

Part of Fin Posillipo SpA, Petrone Group Srl is a pharmaceutical wholesaler and supplier. The company is based in Naples, Italy. The Italian company was founded in 1965 by Carmine Petrone, Fernanda Petrone. The CEO is Pierluigi Petrone.

Pharmaidea SRL operates as a pharmaceutical company. It engages in the marketing, sales, provision of scientific information, and product distribution. The company was founded in 2000 and is headquartered in Travagliato, Italy.

Fin Posillipo SpA provides financial and business consulting services. It helps small and medium-sized enterprises in the health and pharmaceutical sectors such as financial advice and fiscal and administrative consulting. The company was founded in 1989 and is headquartered in Naples, Italy.

STM Pharma PRO, Petrone Group provides pharmaceutical logistics and clinical trial services. The private company is based in Naples, Italy. The Italian company specializes in managing experimental drugs and clinical studies.

Part of ICU Medical, Inc., ICU Medical Italia Srl is a medical device company based in Rome, Italy. The Italian company is trusted by clinicians worldwide for their innovative, cost-effective medical devices that are safe, life-saving, and life-enhancing. The company's Tego Connector is designed to help protect patients' catheters from contamination and increased risk of catheter-related bloodstream infections (CRBSIs) during hemodialysis and apheresis applications.

Newcleo Ltd. is a British company that is disrupting the nuclear energy industry to play its part in climate change mitigation and decarbonization. Newcleo is based in an undisclosed location. The company is focused on reducing the environmental impact of nuclear fission and providing safe and clean energy to meet the growing energy needs. Newcleo has announced an agreement to purchase the outstanding shares of the Rütschi Group for a consideration of EUR 68.9 million. The company is planning ahead to work together with potential local, regional, and international suppliers to maximize the opportunities that Newcleo can bring. The company was founded in 2021 by Elisabeth Rizzotti and Stefano Buono, who has been the CEO since 2021.

Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA.

Corflow Therapeutics AG is a company based in Switzerland that is developing proprietary technologies to measure the coronary microvascular status and provide therapy to the compromised coronary microcirculation at the same time in the catheter laboratory. The Swiss company's focus is on treating microvascular obstruction (MVO) after an acute heart attack, which is documented to be an independent marker leading to costly complications such as heart failure. Corflow's technologies may enable interventional cardiologists to treat MVO in severe heart attack patients, thereby potentially reducing the short- and long-term complication rates in these patients. The company was founded in 2016 by Martin T. Rothman and Robert S. Schwartz.

The International Union of Angiology operates a society for various fields related to vascular health, including vascular biology, vascular medicine, vascular surgery, endovascular interventions, and phlebology. The private company is based in Rome, Italy.

The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research.

The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023.

Molipharma SRL is a French company that focuses on researching and developing new drugs and diagnostics for the prediction, identification, and treatment of mainly female oncological diseases. Molipharma is based in Campobasso, FR, and the CEO of the private company is Americo Cicchetti. The company study new solutions that exploit next-generation genomic analysis and personalized pharmacological therapies. The company also collaborates with partners and publishes scientific content and information in the field of gynecology and obstetrics.

Clinical Trial Center SpA engages in research and development activities. It specializes in the fields of natural sciences and engineering. The company was founded in 2013 and is headquartered in Rome, Italy.

Betaglue Technologies SpA is a holding company, which engages in the provision of medical technology and oncology research services. The company was founded by Francesco Izzo and is headquartered in Naples, Italy.

Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania.

Global Emerging Markets Ltd. is an alternative investment group with a focus on emerging markets. With operations in various countries, the American company manages a diverse set of investment vehicles that offer different risk-adjusted returns and liquidity profiles. The company's investment vehicles provide a diversified portfolio of asset classes that span the private investing spectrum, including small-mid cap management buyouts, private investments in public equities (PIPES), and select venture investments. The company has completed 500 transactions in 70 countries and manages a total of $3.40 billion in assets.

GEM Group, Inc. provides marketing communications services in sport and entertainment. It specializes in event marketing, direct marketing, branding and promotion marketing. The company was founded in 1957 and is headquartered in Valley Cottage, NY.

Part of Global Emerging Markets Ltd., Gem Global Yield Fund LLC SCS provides investment services. The company is based in New York, NY.

Hapoalim Securities USA, Inc. (Hapoalim Securities) is a registered broker/dealer headquartered in New York City. The firm is a subsidiary of PCM-HSU Holdings, Inc., which is owned by Bank Hapoalim BM (TLV: POLI) in Israel. Founded in 1993, Hapoalim Securities specializes in value added investment strategy services and products for institutional and high net-worth private investors. The firm combines a full product offering with international capability. They seek to provide investors with access to Israeli financial markets and companies.